Literature DB >> 16463278

Predicting the three-dimensional structure of human P-glycoprotein in absence of ATP by computational techniques embodying crosslinking data: insight into the mechanism of ligand migration and binding sites.

Stéphane Vandevuer1, Françoise Van Bambeke, Paul M Tulkens, Martine Prévost.   

Abstract

P-glycoprotein is a membrane protein involved in the phenomenon of multidrug resistance. Its activity and transport function have been largely characterized by various biochemical studies and a low-resolution image has been obtained by electron microscopy. Obtaining a high-resolution structure is, however, still remote due to the inherent difficulties in the experimental determination of membrane protein structures. We present here a three-dimensional (3D) atomic model of P-glycoprotein in absence of ATP. This model was obtained using a combination of computational techniques including comparative modeling and rigid body dynamics simulations that embody all available cysteine disulfide crosslinking data characterizing the whole protein in absence of ATP. The model features rather well most of the experimental interresidue distances derived both in the transmembrane domains and in the nucleotide binding domains. The model is also in good agreement with electron microscopy data, particularly in terms of size and topology. It features a large cavity detected in the protein core into which seven ligands were successfully docked. Their predicted affinity correlates well with experimental values. Locations of docked ligands compare favorably with those suggested by cysteine-scanning data. The finding of different positions both for a single ligand and for different ligands corroborates the experimental evidence indicating the existence of multiple drug binding sites. The interactions identified between P-glycoprotein and the docked ligands reveal that different types of interactions such as H-bonds, pi-pi and cation-pi interactions occur in agreement with a recently proposed pharmacophore model of P-glycoprotein ligands. Furthermore, the model also displays a lateral opening located in the transmembrane domains connecting the lipid bilayer to the central cavity. This feature supports rather well the commonly admitted mechanism of substrate uptake from the lipid bilayer. We propose that this 3D model may be an important tool to understand the structure-function relationship of P-glycoprotein. (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16463278     DOI: 10.1002/prot.20892

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  7 in total

1.  P-glycoprotein in proteoliposomes with low residual detergent: the effects of cholesterol.

Authors:  Karsten Bucher; Sara Belli; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2007-05-12       Impact factor: 4.200

2.  Modulation of the cellular accumulation and intracellular activity of daptomycin towards phagocytized Staphylococcus aureus by the P-glycoprotein (MDR1) efflux transporter in human THP-1 macrophages and madin-darby canine kidney cells.

Authors:  Sandrine Lemaire; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2007-06-04       Impact factor: 5.191

3.  Molecular models of human P-glycoprotein in two different catalytic states.

Authors:  Jean-Paul Becker; Grégoire Depret; Françoise Van Bambeke; Paul M Tulkens; Martine Prévost
Journal:  BMC Struct Biol       Date:  2009-01-22

4.  Binding site of ABC transporter homology models confirmed by ABCB1 crystal structure.

Authors:  Aina W Ravna; Ingebrigt Sylte; Georg Sager
Journal:  Theor Biol Med Model       Date:  2009-09-04       Impact factor: 2.432

Review 5.  Impact of the Recent Mouse P-Glycoprotein Structure for Structure-Based Ligand Design.

Authors:  Freya Klepsch; Gerhard F Ecker
Journal:  Mol Inform       Date:  2010-04-20       Impact factor: 3.353

6.  Molecular model of the outward facing state of the human P-glycoprotein (ABCB1), and comparison to a model of the human MRP5 (ABCC5).

Authors:  Aina W Ravna; Ingebrigt Sylte; Georg Sager
Journal:  Theor Biol Med Model       Date:  2007-09-06       Impact factor: 2.432

7.  Generating inhibitors of P-glycoprotein: where to, now?

Authors:  Emily Crowley; Christopher A McDevitt; Richard Callaghan
Journal:  Methods Mol Biol       Date:  2010
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.